Surface Oncology, Inc.

SURFCIK 0001718108 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed May 1, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0008

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Surface Oncology, Inc.

Name	Roles	Filings
Goater Jeff	Director	3
Rath Henry C.	Officer	3
Grayzel David S.	Director	2
Hickey Benjamin	Director	2
Sigal Charles Elliott	Director	2

Showing 6-10 of 17

Per pagePrevPage 2 of 4Next

All filings

42 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Aug 11, 2023	Fees Jessica Chief Financial Officer	SSale	9,434	$0.94	$8,868
Aug 11, 2023	Adams Chandra Deputy GC	SSale	3,901	$0.94	$3,667
Aug 11, 2023	Oneill Alison Chief Medical Officer	SSale	7,042	$0.94	$6,619
Mar 3, 2023	Palombella Vito J. Chief Scientific Officer	Holdings only	-	-	-
Mar 3, 2023	Fees Jessica Chief Financial Officer	Holdings only	-	-	-

Showing 11-15 of 42

Per pagePrevPage 3 of 9Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value